92Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Portugal
Neuroscience Intelligence
Portugal neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #24 of 50 · Data maturity A · Research score 36.5 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.
32Recruiting trials
62Publications
73Institutions
Executive interpretation
Portugal ranks #24 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Hoffmann-La Roche103 recruiting
Bial - Portela C S.A.100 recruiting
Merck Sharp & Dohme LLC55 recruiting
University of Coimbra43 recruiting
Boehringer Ingelheim40 recruiting
Novo Nordisk A/S20 recruiting
Aveiro University21 recruiting
Genzyme, a Sanofi Company20 recruiting
Celgene20 recruiting
GlaxoSmithKline20 recruiting
Disease activity
Alzheimers18trials
Parkinsons18trials
Epilepsy12trials
Multiple Sclerosis9trials
Stroke5trials
Pain Neuropathy4trials
Schizophrenia3trials
Autism3trials
Other Psychiatry3trials
Migraine Headache3trials
Research institutions
Escola Superior de Saúde Egas MonizOpenAlexlinked institution
University of AlgarveOpenAlexlinked institution
Sociedade Portuguesa de CardiologiaOpenAlexlinked institution
Hospital de São JoãoOpenAlexlinked institution
Instituto Nacional de Investigação Agrária e VeterináriaOpenAlexlinked institution
Centro de Investigação e de Tecnologias Agro-Ambientais e BiologicasOpenAlexlinked institution
Centro Hospitalar Psiquiátrico de CoimbraOpenAlexlinked institution
Centro Hospitalar de Vila Nova de GaiaOpenAlexlinked institution
Instituto de TelecomunicaçõesOpenAlexlinked institution
Centro de Estatística e AplicaçõesOpenAlexlinked institution
Clinical evidence trail
NCT07544498XR2ESILIENCE - XR-Based Resilience Training for Stress and Mental Health in Healthcare WorkersNOT_YET_RECRUITING
NCT07456631ACTsocially: The (Dis)Similarities of ACT for Changing Internalizing and Externalizing Symptomatology in AdolescenceRECRUITING
NCT07174310A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseRECRUITING
NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)RECRUITING
NCT06966700A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RECRUITING
NCT06961006A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)RECRUITING
NCT06887192A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisRECRUITING
Research evidence trail
PUBMEDIrritable versus euphoric mania in psychiatric inpatients: a retrospective study of 251 inpatient episodes.2027-01-01
PUBMEDLocus Coeruleus mediates the pharmacological effects of 2-Pentadecyl-2-oxazoline in a mouse model of neuropathic pain.2026-12-15
PUBMEDIn-hospital outcomes of acute myocardial infarction hospitalizations with versus without registered bipolar disorder: A nationwide administrative-data study.2026-12-01
PUBMEDDisrupted metabolic support of intrinsic brain rhythms as a driver of spatiotemporal fragmentation in schizophrenia.2026-12-01
PUBMEDReal-world applicability of the 2024 McDonald criteria for multiple sclerosis diagnosis in Portugal.2026-11-01
PUBMEDPilot MRI study of carbon monoxide (CO) against ischemic stroke in mice: blood brain barrier integrity and metabolic pattern.2026-11-01
PUBMEDDysfunctional Brain Circuits Overlap in Lesional and Idiopathic Obsessive-Compulsive Disorder.2026-11-01
PUBMEDData-driven registration and modeling of brain deformation for image-guided neurosurgery.2026-11-01
PUBMEDMiR‑204‑5p modulates glial morphology and apomorphine‑induced rotational asymmetry without dopaminergic neuroprotection in a preclinical mouse model of Parkinson's disease.2026-10-22
PUBMEDA late-onset slowly progressive dystrophic-myasthenic phenotype expands the clinical spectrum of TOR1AIP1-related disease.2026-10-14
PUBMEDRevisiting the muscle spindle in ALS: Implications for spinal motor network dysfunction.2026-10-14
PUBMEDCaregiver Burden and Its Determinants After Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease: A Cross-Sectional Long-Term Follow-Up Study.2026-10-12
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.